14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
BYLD vs IMTB: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, iShares Yield Optimized Bond ETF (BYLD) is the stronger overall head-to-head candidate over iShares Core 5-10 Year USD Bond ETF (IMTB) in the Tradestie Institutional Equity Comparison Engine, winning 0–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BYLD carries a Unified Composite Score of 41.6/100 (SELL) at $21.57 (N/M Forward P/E, N/A operating margin), whereas IMTB carries 42.5/100 (HOLD) at $41.66 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While IMTB currently prints a higher short-term Unified Composite Score (42.5/100 HOLD vs. BYLD 41.6/100 SELL), BYLD captures the overall institutional head-to-head verdict (0–2 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: BYLD is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 38.5); meanwhile IMTB is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BYLD vs IMTB. Trailing 12-month operating profitability (BYLD N/A vs IMTB N/A) and valuation multiples (BYLD N/M vs IMTB N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ BYLD vs IMTB Key Questions & Quantitative Answers
As of Nov 16, 2026, iShares Yield Optimized Bond ETF (BYLD) is the stronger overall head-to-head candidate over iShares Core 5-10 Year USD Bond ETF (IMTB) in the Tradestie Institutional Equity Comparison Engine, winning 0–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). BYLD carries a Unified Composite Score of 41.6/100 (SELL) at $21.57 (N/M Forward P/E, N/A operating margin), whereas IMTB carries 42.5/100 (HOLD) at $41.66 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While IMTB currently prints a higher short-term Unified Composite Score (42.5/100 HOLD vs. BYLD 41.6/100 SELL), BYLD captures the overall institutional head-to-head verdict (0–2 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: BYLD is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 38.5); meanwhile IMTB is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
BYLD and IMTB split Growth & Scale metrics: BYLD posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IMTB at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, BYLD generates N/A in USD-normalized revenue versus N/A for IMTB. In operating R&D and SG&A reinvestment, BYLD deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IMTB.
BYLD and IMTB trade at balanced relative valuation multiples. BYLD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IMTB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BYLD (N/A ROE) versus IMTB (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, BYLD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.17β · 6% Vol realized risk). By comparison, IMTB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.13β · 6% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.